AOD9604 for Sale: Molecular Integrity & Sourcing Guide

In the fields of clinical nutrition, lipid kinetics, and endocrine research, investigating targeted metabolic pathways without systemic cross-reactivity is a primary objective. Among the most specialized peptide sequences engineered for this purpose is AOD9604 (Anti-Obesity Drug 9604).

When procurement specialists or biomedical laboratories search for certified AOD9604 for sale, they are typically looking to acquire a highly purified synthetic peptide capable of isolating the fat-reducing properties of full-length Human Growth Hormone (hGH) while completely eliminating its unwanted, diabetogenic side effects (Stier, 2013).

Because the market for research-grade peptides contains significant variations in manufacturing quality, purchasing agents must evaluate technical specifications rather than relying on standard commercial labeling. Sourcing substandard or improperly cyclized sequences can compromise cell-line assays and lead to unstable data.

This guide details the structural biochemistry of the compound, its specific lipolytic mechanisms, and the strict analytical standards required when looking for authentic AOD9604 for sale.

What is AOD9604? Structural Composition

AOD9604 is a modified peptide fragment derived from the C-terminus of human growth hormone, specifically isolating residues 177–191 of the intact 191-amino-acid somatropin chain (Moré, 2014).

Full hGH Molecule (1-191 Amino Acids)
┌──────────────────────────────────────────────────────────────┐
│ Base Chain (1...........................................176) │ [177-191 Fragment]
└──────────────────────────────────────────────────────────────┴───────┬───────┘
                                                                        │
                                                                        ▼
                                                   Modified Sequence: Tyr-hGH(177-191)
                                                   ┌─────────────────────────────────┐
                                                   │ Tyr - Leu - Arg - Ile - Val -   │
                                                   │ Gln - Cys* - Arg - Ser - Val -  │
                                                   │ Glu - Gly - Ser - Cys* - Gly -  │
                                                   │ Phe                             │
                                                   └─────────────────────────────────┘
                                                     *Disulfide Bridge (Cyclization)

To ensure structural stability and resist rapid enzymatic breakdown, the peptide features two primary modifications:

1. N-Terminal Stabilization: A synthetic tyrosine (Tyr) residue is attached to the N-terminal end of the chain (Stier, 2013).

2. Cyclization: A critical disulfide bond forms between the two internal cysteine (Cys) residues, creating a stable loop structure that mirrors the natural 3D shape of the homologous region in native hGH (Moré, 2014).

By utilizing solid-phase peptide synthesis (SPPS) to isolate this fragment, researchers can observe the distinct lipid-clearing characteristics of growth hormone without triggering downstream systemic growth loops (Stier, 2013).

Mechanism of Action: Isolating Lipolysis

The primary reason laboratories seek AOD9604 for sale is its unique ability to regulate fat metabolism without interacting with the primary Human Growth Hormone Receptor (GHR) (Harpur et al., 2023). This provides two major biochemical advantages over full-length somatropin:

1. Direct Stimulation of Fat Breakdown

When researchers introduce certified AOD9604 for sale into experimental models, the peptide acts directly on mature white adipose tissue to stimulate lipolysis (the breakdown of stored triglycerides into free fatty acids) and inhibit lipogenesis (the formation of new fat stores) (Moré, 2014).

Animal models indicate that these lipolytic actions are supported by an up-regulation of repressed $\beta_3$-adrenergic receptor ($\beta_3\text{-AR}$) RNA expression, which restores normal metabolic sensitivity in obese fat profiles (Heffernan et al., 2001).

2. Complete Avoidance of Glycemic Complications

Full-length hGH treatment carries systemic risks, such as elevated Insulin-Like Growth Factor 1 (IGF-1) production, glucose intolerance, hyperinsulinemia, and insulin resistance (Stier, 2013).

The molecular structure of AOD9604 for sale completely bypasses these pathways. It does not bind to the liver receptors responsible for generating IGF-1, meaning it can regulate lipid turnover without causing joint swelling, tissue enlargement, or changes in blood sugar metabolism (Stier, 2013).

Critical Metrics for Sourcing AOD9604

When assessing options for high-grade AOD9604 for sale, research facilities must look past low costs and carefully review verified batch analytics. Peptide chains sold via unverified online vendors are frequently marketed under the label “research chemicals” to bypass regulatory oversight, presenting a high risk of containing unlisted contaminants or truncated sequences (Mendias, n.d.).

Technical Benchmarks to Demand

Before executing a procurement order for an AOD9604 for sale listing, confirm the following standards:

• Purity Threshold: A minimum purity of 95% (ideally $\ge 98\%$) verified via High-Performance Liquid Chromatography (HPLC).

• Mass Verification: Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) mass spectrometry must confirm the correct molecular weight and profile of the Tyr-hGH(177-191) chain.

• Cyclization Status: The documentation must verify complete disulfide bridging. Uncyclized or linear variations of the fragment lose their biological activity and fail to accurately trigger lipolytic pathways.

• Low Endotoxin Levels: Ensure total endotoxins measure below $0.1 \text{ EU/mg}$ to prevent acute inflammatory cell-culture reactions.

Storage and Handling Protocols

AOD9604 is a delicate peptide that requires strict environmental controls to preserve its structural disulfide bond and prevent rapid hydrolysis.

Preservation Environments

• Lyophilized Powder: Store dry vials in a sealed container protected from light. Keep them at 2°C to 8°C for short-term projects, or in a deep freeze at -20°C to -80°C for long-term storage to prevent peptide degradation.

• Reconstituted Liquid: Once mixed with sterile physiological saline or bacteriostatic water, the solution becomes fragile. Keep it refrigerated continuously at 2°C to 8°C and use within 7 to 10 days. Never freeze AOD9604 once it is in liquid form, as ice crystal formation will break its delicate internal bonds.

Reconstitution Best Practices

Gently slide the liquid diluent down the interior glass wall of the vial. Avoid spraying the liquid directly onto the lyophilized cake. Slowly roll the vial between your hands until the powder completely dissolves. Never shake or vortex the container, as violent mechanical mixing will cause micro-foaming and denature the peptide structure.

Conclusion: Verifying Your Sourcing Pipeline

Acquiring verified batches of AOD9604 for sale for scientific evaluation requires prioritizing raw analytical verification over generic commercial descriptions. By insisting on independent HPLC and mass spectrometry documentation, laboratories can ensure they receive a properly cyclized, highly pure Tyr-hGH(177-191) sequence.

This level of quality control eliminates experimental variables and ensures consistent, reproducible data in metabolic and lipolytic assays.

Frequently Asked Questions

What is the primary benefit of tracking down a high-quality AOD9604 for sale batch?

Securing an established source of AOD9604 for sale ensures that your laboratory assays utilize a highly pure peptide with zero uncoupled amino acid variants. This reduces experimental errors and ensures the observed biological effects are driven entirely by the targeted fragment.

Does AOD9604 influence vertical growth or bone elongation models?

No. Because it lacks the N-terminal residues of the full growth hormone chain, AOD9604 does not activate the pathways responsible for tissue hyperplasia or bone matrix elongation, focusing its effects purely on lipid metabolism.

How should a lab handle an AOD9604 for sale shipment upon receipt?

Upon arrival, the lyophilized vials must be immediately transitioned into temperature-controlled storage. For short-term experimental scheduling, maintain the vials at 4°C, or store them at -20°C for long-term preservation.

Why is complete cyclization critical for AOD9604 efficacy?

The internal disulfide bridge creates a rigid loop configuration that allows the peptide to precisely recognize and fit target fat-cell binding sites. A linear or uncyclized sequence lacks this spatial architecture, dropping its biological potency significantly.

Is AOD9604 for sale through research vendors legal for clinical human therapies?

No. All formulations obtained via standard research catalogs are strictly designated for in vitro cellular assays and animal testing models. They do not possess therapeutic approval from global regulatory bodies like the FDA for human use or weight loss therapies.

References

Harpur, C. M., West, A. C., Le Page, M. A., Lam, M., Hodges, C., Oseghale, O., Gearing, A. J., & Tate, M. D. (2023). Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection. Clinical & Translational Immunology, 12(3). https://doi.org/10.1002/cti2.1443

Cited by: 13

Heffernan, M., Summers, R. J., Thorburn, A., Ogru, E., Gianello, R., Jiang, W.-J., & Ng, F. M. (2001). The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice and $\beta_3$-AR Knock-Out Mice. Endocrinology, 142(12), 5182-5189. https://doi.org/10.1210/en.142.12.5182

Cited by: 71

Mendias, C. L. (n.d.). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Preprints.org.

Cited by: 5

Moré. (2014). Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health. Journal of Endocrinology and Metabolism, 4(3). https://doi.org/10.14740/jem213w

Cited by: 12

Stier. (2013). Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Journal of Endocrinology and Metabolism, 3(1-2). https://doi.org/10.4021/jem157w

Cited by: 24